Understanding Your Biomarker Report

LUNGevity’s Patient Education Booklet – “What You Need to Know About Reading a Biomarker Test Report”

This educational resource is designed to help lung cancer patients and caregivers understand biomarker testing and how to interpret test results. It empowers patients to make informed decisions about their treatment options and communicate effectively with their healthcare team.

Key Features

• Biomarker Testing Overview: Explains what biomarkers are, why testing is important, and when it should be done.
• Reading Test Results: Guides patients through understanding test summaries, mutation types, diagnostic methods (e.g., NGS, IHC), and variant details.
• Therapy Options: Details targeted therapies and immunotherapies based on specific biomarkers, including PD-L1 levels.
• Clinical Trials: Offers advice on exploring clinical trial opportunities and discussing them with healthcare providers.
• Glossary & Notes: Includes definitions of key terms and space for personal notes.

Support Resources

• LUNGevity LifeLine Program: Peer-to-peer support from survivors and caregivers.
• Toll-Free HELPLine: Access to oncology social workers for guidance.
• Online Communities & Conferences: Opportunities for connection and education.

Collaborative Partners

This material was created in partnership with:

• Association of Community Cancer Centers (ACCC)
• Association for Molecular Pathology (AMP)
• Advanced Practitioner Society for Hematology and Oncology (APSHO)
• International Association for the Study of Lung Cancer (IASLC)